Mark Lackner

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of human epididymis protein 4 (HE4) for assessing responsivenes...
- Patent number 11,440,969
- Issue date Sep 13, 2022
- Genentech, Inc.
- Mark Lackner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetic variations associated with drug resistance
- Patent number 11,021,711
- Issue date Jun 1, 2021
- Genentech, Inc.
- Mark Lackner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetic variations associated with drug resistance
- Patent number 9,879,267
- Issue date Jan 30, 2018
- Genentech, Inc.
- Mark Lackner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for prostate cancer analysis
- Patent number 9,632,091
- Issue date Apr 25, 2017
- Genentech, Inc.
- Siminder Atwal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMBINATION AND TUMOR TREATMENT
- Publication number 20250017921
- Publication date Jan 16, 2025
- IDEAYA Biosciences Inc.
- Zineb Mounir
- G01 - MEASURING TESTING
Information Patent Application
USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENES...
- Publication number 20230064677
- Publication date Mar 2, 2023
- Genentech, Inc.
- Mark LACKNER
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF CANCER HAVING GNAQ OR GNA11 GENETIC MUTATIONS WITH PRO...
- Publication number 20220305008
- Publication date Sep 29, 2022
- John Knox
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENES...
- Publication number 20190233538
- Publication date Aug 1, 2019
- Genentech, Inc.
- Mark LACKNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE
- Publication number 20180298387
- Publication date Oct 18, 2018
- Genentech, Inc.
- Mark Lackner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
- Publication number 20160274116
- Publication date Sep 22, 2016
- Genentech, Inc.
- Siminder Atwal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
- Publication number 20130143237
- Publication date Jun 6, 2013
- Genentech, Inc.
- Siminder Atwal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE
- Publication number 20110177099
- Publication date Jul 21, 2011
- Mark Lackner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS FOR IGF-1R INHIBITOR THERAPY
- Publication number 20100316639
- Publication date Dec 16, 2010
- Genentech, Inc.
- MARK R. LACKNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Rabs as modifiers of the p53 pathway and methods of use
- Publication number 20060084063
- Publication date Apr 20, 2006
- Michael R Costa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of RabGGT and methods of use thereof
- Publication number 20040142888
- Publication date Jul 22, 2004
- Veeraswamy Manne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Lackner

Person

Patents Grantslast 30 patents

Use of human epididymis protein 4 (HE4) for assessing responsivenes...

Genetic variations associated with drug resistance

Genetic variations associated with drug resistance

Compositions and methods for prostate cancer analysis

Patents Applicationslast 30 patents

PHARMACEUTICAL COMBINATION AND TUMOR TREATMENT

USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENES...

TREATMENT OF CANCER HAVING GNAQ OR GNA11 GENETIC MUTATIONS WITH PRO...

USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENES...

GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE

COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS

COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS

GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE

BIOMARKERS FOR IGF-1R INHIBITOR THERAPY

Rabs as modifiers of the p53 pathway and methods of use

Modulators of RabGGT and methods of use thereof